Hematopoietic Stem Cells Impact Factor
The
impact factor of journal produces quantitative assessment tool for evaluating, grading, comparing and sorting
journals of related kind. It contemplates the average number of citations to recent
articles published in
social science and science
journals in a particular period or year, and is customarily used as a proxy for the relative significance of a journal within its discipline.
Hematopoietic stem
cells are the most frequently transplanted adult stem cell. Currently, they are used for the treatment of acquired diseases and several genetic including autoimmune disorders, blood cancers, and
hematopoietic defects.
Hematopoietic stem
cells are absolute candidates for
gene therapy applications because they enchant the capacity for functionality and self-replication to generate the entire
hematopoietic lineage, thus facilitating expression of a transgene product and amplification of genetically-modified
cells from a multitude of
hematopoietic cell types.
High Impact List of Articles
-
Centralized management of clinical trial feasibility requests: a single center database analysis from 2008 to 2015
Dorothee Arenz, Timo Siepmann and Oliver A Cornely
Research Paper: Clinical Investigation
-
Centralized management of clinical trial feasibility requests: a single center database analysis from 2008 to 2015
Dorothee Arenz, Timo Siepmann and Oliver A Cornely
Research Paper: Clinical Investigation
-
Centralized management of clinical trial feasibility requests: a single center database analysis from 2008 to 2015
Dorothee Arenz, Timo Siepmann and Oliver A Cornely
Research Paper: Clinical Investigation
-
Centralized management of clinical trial feasibility requests: a single center database analysis from 2008 to 2015
Dorothee Arenz, Timo Siepmann and Oliver A Cornely
Research Paper: Clinical Investigation
-
Centralized management of clinical trial feasibility requests: a single center database analysis from 2008 to 2015
Dorothee Arenz, Timo Siepmann and Oliver A Cornely
Research Paper: Clinical Investigation
-
Centralized management of clinical trial feasibility requests: a single center database analysis from 2008 to 2015
Dorothee Arenz, Timo Siepmann and Oliver A Cornely
Research Paper: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Adaptive Clinical Trials
Zoran Antonijevic
Foreword: Clinical Investigation
-
Adaptive Clinical Trials
Zoran Antonijevic
Foreword: Clinical Investigation
-
Adaptive Clinical Trials
Zoran Antonijevic
Foreword: Clinical Investigation
-
Adaptive Clinical Trials
Zoran Antonijevic
Foreword: Clinical Investigation
-
Adaptive Clinical Trials
Zoran Antonijevic
Foreword: Clinical Investigation
-
Adaptive Clinical Trials
Zoran Antonijevic
Foreword: Clinical Investigation
-
A vaccine for leukemia: one step closer? Cure-oriented WT1 peptide vaccination therapy is being developed
Yoshihiro Oka
Editorial: Clinical Investigation
-
A vaccine for leukemia: one step closer? Cure-oriented WT1 peptide vaccination therapy is being developed
Yoshihiro Oka
Editorial: Clinical Investigation
-
A vaccine for leukemia: one step closer? Cure-oriented WT1 peptide vaccination therapy is being developed
Yoshihiro Oka
Editorial: Clinical Investigation
-
A vaccine for leukemia: one step closer? Cure-oriented WT1 peptide vaccination therapy is being developed
Yoshihiro Oka
Editorial: Clinical Investigation
-
A vaccine for leukemia: one step closer? Cure-oriented WT1 peptide vaccination therapy is being developed
Yoshihiro Oka
Editorial: Clinical Investigation
-
A vaccine for leukemia: one step closer? Cure-oriented WT1 peptide vaccination therapy is being developed
Yoshihiro Oka
Editorial: Clinical Investigation
-
New considerations in the design of clinical trials for spondyloarthritis
Robert Landewe ,Desiree van der Heijde
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for spondyloarthritis
Robert Landewe ,Desiree van der Heijde
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for spondyloarthritis
Robert Landewe ,Desiree van der Heijde
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for spondyloarthritis
Robert Landewe ,Desiree van der Heijde
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for spondyloarthritis
Robert Landewe ,Desiree van der Heijde
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for spondyloarthritis
Robert Landewe ,Desiree van der Heijde
Review Article: Clinical Investigation
Relevant Topics in Clinical